Intuitive Surgical's (ISRG) Buy Rating Reiterated at BTIG Research

Key Points

• BTIG Research reiterated a "buy" rating on Intuitive Surgical with a $616 price target, implying roughly a 35.4% upside from the prior close.
• Intuitive posted a strong quarter—EPS of $2.53 vs. $2.27 expected and revenue of $2.87B vs. $2.72B—driving 18.8% year‑over‑year revenue growth and bolstering analyst optimism.
• Offsetting the bullish outlook, insiders sold about 32,943 shares (~$17.3M) over the last three months and now hold only 0.60% of the stock, indicating notable insider trimming.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report)'s stock had its "buy" rating restated by investment analysts at BTIG Research in a research note issued on Friday,Benzinga reports. They presently have a $616.00 target price on the medical equipment provider's stock. BTIG Research's target price indicates a potential upside of 35.40% from the stock's previous close.

Other equities research analysts have also issued research reports about the company. Weiss Ratings reissued a "hold (c+)" rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Royal Bank Of Canada lifted their price target on Intuitive Surgical from $625.00 to $650.00 and gave the company an "outperform" rating in a research report on Wednesday, December 17th. Barclays set a $712.00 price objective on shares of Intuitive Surgical and gave the stock an "overweight" rating in a research report on Monday, January 26th. UBS Group cut their price target on shares of Intuitive Surgical from $570.00 to $550.00 and set a "neutral" rating for the company in a research note on Tuesday, March 17th. Finally, The Goldman Sachs Group lowered their price objective on shares of Intuitive Surgical from $714.00 to $609.00 and set a "buy" rating on the stock in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $607.00.

Intuitive Surgical Trading Down 1.6%

Shares of Intuitive Surgical stock opened at $454.94 on Friday. The company's 50-day moving average price is $482.22 and its 200-day moving average price is $513.65. Intuitive Surgical has a 12-month low of $427.84 and a 12-month high of $603.88. The company has a market cap of $161.56 billion, a price-to-earnings ratio of 57.66, a PEG ratio of 3.61 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts' consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same quarter in the prior year, the firm posted $2.21 EPS. Intuitive Surgical's revenue was up 18.8% on a year-over-year basis. On average, sell-side analysts predict that Intuitive Surgical will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,362 shares of the company's stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the completion of the sale, the senior vice president owned 3,554 shares of the company's stock, valued at approximately $1,772,308.72. This represents a 39.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gary S. Guthart sold 24,500 shares of the stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the transaction, the director directly owned 3,694 shares in the company, valued at approximately $1,958,189.40. This represents a 86.90% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 32,943 shares of company stock valued at $17,279,568. 0.60% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Holos Integrated Wealth LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at about $25,000. Newbridge Financial Services Group Inc. lifted its position in Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 33 shares during the last quarter. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical during the third quarter valued at approximately $27,000. Olistico Wealth LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $28,000. Finally, Caitlin John LLC bought a new position in shares of Intuitive Surgical in the third quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.